US Stock MarketDetailed Quotes

INDP Indaptus Therapeutics

Watchlist
  • 2.240
  • -0.250-10.04%
Close Mar 28 16:00 ET
  • 2.290
  • +0.050+2.23%
Post 17:28 ET
19.13MMarket Cap-1224P/E (TTM)

Indaptus Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
9.84%16.38M
2.27%4.18M
19.59%4.25M
-9.67%3.5M
30.95%4.46M
92.92%14.91M
26.99%4.09M
5.48%3.55M
631.92%3.87M
454.11%3.4M
Selling and administrative expenses
1.99%8.76M
-1.39%2.15M
4.05%2.02M
-14.74%2.01M
22.34%2.58M
64.93%8.59M
-4.34%2.18M
-27.24%1.94M
1,618.28%2.36M
1,594.09%2.1M
-General and administrative expense
1.99%8.76M
-1.39%2.15M
4.05%2.02M
-14.74%2.01M
22.34%2.58M
64.93%8.59M
-4.34%2.18M
-27.24%1.94M
1,618.28%2.36M
1,594.09%2.1M
Research and development costs
20.51%7.62M
6.42%2.03M
38.34%2.23M
-1.70%1.48M
44.93%1.88M
150.66%6.32M
102.39%1.91M
130.70%1.61M
285.09%1.51M
164.86%1.3M
Operating profit
-9.84%-16.38M
-2.27%-4.18M
-19.59%-4.25M
9.67%-3.5M
-30.95%-4.46M
-92.92%-14.91M
-26.99%-4.09M
-5.48%-3.55M
-631.92%-3.87M
-454.11%-3.4M
Net non-operating interest income expense
Other net income (expense)
62.39%955K
-58.99%176.85K
278.29%326.02K
641.15%250.2K
446.95%201.93K
588.11K
431.25K
10,321.28%86.18K
156.40%33.76K
2,275.74%36.92K
Other non- operating income (expenses)
62.39%955K
-58.99%176.85K
278.29%326.02K
641.15%250.2K
446.95%201.93K
--588.11K
--431.25K
10,321.28%86.18K
156.40%33.76K
2,275.74%36.92K
Income before tax
-7.68%-15.42M
-9.49%-4M
-13.16%-3.92M
15.39%-3.25M
-26.39%-4.25M
-85.74%-14.32M
-13.66%-3.66M
-2.95%-3.47M
-644.07%-3.84M
-449.48%-3.37M
Income tax
Net income
-7.68%-15.42M
-9.49%-4M
-13.16%-3.92M
15.39%-3.25M
-26.39%-4.25M
-85.74%-14.32M
-13.66%-3.66M
-2.95%-3.47M
-644.07%-3.84M
-449.48%-3.37M
Net income continuous Operations
-7.68%-15.42M
-9.49%-4M
-13.16%-3.92M
15.39%-3.25M
-26.39%-4.25M
-85.74%-14.32M
-13.66%-3.66M
-2.95%-3.47M
-644.07%-3.84M
-449.48%-3.37M
Minority interest income
Net income attributable to the parent company
-7.68%-15.42M
-9.49%-4M
-13.16%-3.92M
15.39%-3.25M
-26.39%-4.25M
-85.74%-14.32M
-13.66%-3.66M
-2.95%-3.47M
-644.07%-3.84M
-449.48%-3.37M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-7.68%-15.42M
-9.49%-4M
-13.16%-3.92M
15.39%-3.25M
-26.39%-4.25M
-85.74%-14.32M
-13.66%-3.66M
-2.95%-3.47M
-644.07%-3.84M
-449.48%-3.37M
Basic earnings per share
-5.78%-1.83
-6.82%-0.47
-11.90%-0.47
15.22%-0.39
-24.39%-0.51
8.47%-1.73
-12.98%-0.44
48.15%-0.42
-382.41%-0.46
-261.92%-0.41
Diluted earnings per share
-5.78%-1.83
-6.82%-0.47
-11.90%-0.47
15.22%-0.39
-24.39%-0.51
8.47%-1.73
-12.98%-0.44
48.15%-0.42
-382.41%-0.46
-261.92%-0.41
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 9.84%16.38M2.27%4.18M19.59%4.25M-9.67%3.5M30.95%4.46M92.92%14.91M26.99%4.09M5.48%3.55M631.92%3.87M454.11%3.4M
Selling and administrative expenses 1.99%8.76M-1.39%2.15M4.05%2.02M-14.74%2.01M22.34%2.58M64.93%8.59M-4.34%2.18M-27.24%1.94M1,618.28%2.36M1,594.09%2.1M
-General and administrative expense 1.99%8.76M-1.39%2.15M4.05%2.02M-14.74%2.01M22.34%2.58M64.93%8.59M-4.34%2.18M-27.24%1.94M1,618.28%2.36M1,594.09%2.1M
Research and development costs 20.51%7.62M6.42%2.03M38.34%2.23M-1.70%1.48M44.93%1.88M150.66%6.32M102.39%1.91M130.70%1.61M285.09%1.51M164.86%1.3M
Operating profit -9.84%-16.38M-2.27%-4.18M-19.59%-4.25M9.67%-3.5M-30.95%-4.46M-92.92%-14.91M-26.99%-4.09M-5.48%-3.55M-631.92%-3.87M-454.11%-3.4M
Net non-operating interest income expense
Other net income (expense) 62.39%955K-58.99%176.85K278.29%326.02K641.15%250.2K446.95%201.93K588.11K431.25K10,321.28%86.18K156.40%33.76K2,275.74%36.92K
Other non- operating income (expenses) 62.39%955K-58.99%176.85K278.29%326.02K641.15%250.2K446.95%201.93K--588.11K--431.25K10,321.28%86.18K156.40%33.76K2,275.74%36.92K
Income before tax -7.68%-15.42M-9.49%-4M-13.16%-3.92M15.39%-3.25M-26.39%-4.25M-85.74%-14.32M-13.66%-3.66M-2.95%-3.47M-644.07%-3.84M-449.48%-3.37M
Income tax
Net income -7.68%-15.42M-9.49%-4M-13.16%-3.92M15.39%-3.25M-26.39%-4.25M-85.74%-14.32M-13.66%-3.66M-2.95%-3.47M-644.07%-3.84M-449.48%-3.37M
Net income continuous Operations -7.68%-15.42M-9.49%-4M-13.16%-3.92M15.39%-3.25M-26.39%-4.25M-85.74%-14.32M-13.66%-3.66M-2.95%-3.47M-644.07%-3.84M-449.48%-3.37M
Minority interest income
Net income attributable to the parent company -7.68%-15.42M-9.49%-4M-13.16%-3.92M15.39%-3.25M-26.39%-4.25M-85.74%-14.32M-13.66%-3.66M-2.95%-3.47M-644.07%-3.84M-449.48%-3.37M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -7.68%-15.42M-9.49%-4M-13.16%-3.92M15.39%-3.25M-26.39%-4.25M-85.74%-14.32M-13.66%-3.66M-2.95%-3.47M-644.07%-3.84M-449.48%-3.37M
Basic earnings per share -5.78%-1.83-6.82%-0.47-11.90%-0.4715.22%-0.39-24.39%-0.518.47%-1.73-12.98%-0.4448.15%-0.42-382.41%-0.46-261.92%-0.41
Diluted earnings per share -5.78%-1.83-6.82%-0.47-11.90%-0.4715.22%-0.39-24.39%-0.518.47%-1.73-12.98%-0.4448.15%-0.42-382.41%-0.46-261.92%-0.41
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg